Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)

Ratika Parkash; Steve Doucette; John L. Sapp

doi:10.1161/CIRCEP.117.005663

Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)

Ratika Parkash, Steve Doucette, John L. Sapp

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
文章编号	e005663
期刊	Circulation: Arrhythmia and Electrophysiology
卷	11
期	1
DOI	https://doi.org/10.1161/CIRCEP.117.005663
出版状态	已出版 - 1月 1 2018

!!!ASJC Scopus Subject Areas

心脏病学与心血管医学
生理学（医学）

访问文件

10.1161/CIRCEP.117.005663

其它文件与链接

指纹

探究 'Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)' 的科研主题。它们共同构成独一无二的指纹。

引用此

Parkash, R., Doucette, S., & Sapp, J. L. (2018). Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease). Circulation: Arrhythmia and Electrophysiology, 11(1), 文章 e005663. https://doi.org/10.1161/CIRCEP.117.005663

Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease). / Parkash, Ratika ; Doucette, Steve ; Sapp, John L.
在: Circulation: Arrhythmia and Electrophysiology, 卷 11, 号码 1, e005663, 01.01.2018.

科研成果: 期刊稿件 › 文章 › 同行评审

Parkash, R , Doucette, S & Sapp, JL 2018, 'Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)', Circulation: Arrhythmia and Electrophysiology, 卷 11, 号码 1, e005663. https://doi.org/10.1161/CIRCEP.117.005663

@article{30221a309b544602b2a139928f59b50e,

title = "Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)",

keywords = "anti-arrhythmia agents, catheter ablation, humans, myocardial infarction, ventricular tachycardia",

author = "Ratika Parkash and Steve Doucette and Sapp, {John L.}",

note = "Publisher Copyright: {\textcopyright} 2018 American Heart Association, Inc.",

year = "2018",

month = jan,

day = "1",

doi = "10.1161/CIRCEP.117.005663",

language = "English",

volume = "11",

journal = "Circulation: Arrhythmia and Electrophysiology",

issn = "1941-3149",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Effect of Baseline Antiarrhythmic Drug on Outcomes with Ablation in Ischemic Ventricular Tachycardia

T2 - A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease)

AU - Parkash, Ratika

AU - Doucette, Steve

AU - Sapp, John L.

PY - 2018/1/1

Y1 - 2018/1/1

KW - anti-arrhythmia agents

KW - catheter ablation

KW - humans

KW - myocardial infarction

KW - ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=85055455653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055455653&partnerID=8YFLogxK

U2 - 10.1161/CIRCEP.117.005663

DO - 10.1161/CIRCEP.117.005663

M3 - Article

C2 - 29305400

AN - SCOPUS:85055455653

SN - 1941-3149

VL - 11

JO - Circulation: Arrhythmia and Electrophysiology

JF - Circulation: Arrhythmia and Electrophysiology

IS - 1

M1 - e005663

ER -